T1	Participants 91 151	vulvovaginal and sexual dysfunction in postmenopausal women.
T2	Participants 190 210	postmenopausal women
T3	Participants 532 553	postmenopausal women.
T4	Participants 562 653	Seventy-five postmenopausal women symptomatic for urogenital atrophy and sexual dysfunction
T5	Participants 1412 1424	study groups
T6	Participants 1446 1460	control group.
T7	Participants 1799 1832	symptomatic postmenopausal women.
